Postpartum follow-up of a positive purified protein derivative (PPD) among an indigent population - 18/08/11
Abstract |
Objective |
This study was undertaken to investigate the rates and predictors of follow-up and treatment for postpartum patients with a positive purified protein derivative (PPD).
Study design |
Retrospective cohort study of all women delivered at San Francisco General Hospital in 2000. All patients with a positive PPD were identified and their demographic and PPD follow-up and treatment data were collected and analyzed.
Results |
Among the 1331 patients delivered, the prevalence of a positive PPD was 32% (n=425). Of the 393 patients who had not been previously treated, 42% (n=167) attended a follow-up visit with 42% of these (n=71) actually completing 6 months of therapy. Among different ethnicities, Asian patients were more likely to follow-up at a rate of 52% (P=.03). Patients who received care from the same physician both antepartum and postpartum were more likely to attend and complete therapy at rates of 67% (P < .001) and 62% (P=.01), respectively.
Conclusion |
We found that despite the opportunity given by the interaction with the medical system during pregnancy, only 18% of patients with a positive PPD actually completed therapy.
Le texte complet de cet article est disponible en PDF.Key words : Tuberculosis, Pregnancy, Purified protein derivative, Latent tuberculosis infection
Plan
| Support was from the National Institute of Child Health and Human Development, grant HD01262 to A.C. as a Women's Reproductive Health Research Scholar. Reprints not available from the authors. |
Vol 192 - N° 5
P. 1455-1457 - mai 2005 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
